PS
Pinto Shelly
VP, Finance et Directeur Comptable
OtherF
内部人交易记录
高级管理人员尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the complete record of transactions filed by Pinto Shelly, VP, Finance et Directeur Comptable. Officer active across 1 company, notably ALX Oncology Holdings INC. Aggregated, 22 reports have been logged. Breakdown: 0 buy · 17 sells. Total volume traded: €141k. History available since 28 January 2022. The latest transaction was disclosed on 19 March 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Pinto Shelly
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报22 总计
903 股@ US$2.171.3% 占其流量Common StockSEC:0001193125-26-119703:0
565 股@ US$2.270.8% 占其流量Common StockSEC:0001193125-26-061313:0
3,925 股@ US$1.112.6% 占其流量Common StockSEC:0001193125-26-006374:0
611 股@ US$0.64040.2% 占其流量Common StockSEC:0000950170-25-110102:0
2,011 股@ US$0.45010.6% 占其流量Common StockSEC:0000950170-25-094613:0
1,532 股@ US$0.430.4% 占其流量Common StockSEC:0000950170-25-092232:0
3,000 股0Common StockSEC:0001415889-25-008428:0
550 股@ US$1.15020.5% 占其流量Common StockSEC:0001415889-25-005071:0
2,221 股@ US$1.802.9% 占其流量Common StockSEC:0001415889-25-001120:0
1,426 股@ US$1.58021.6% 占其流量Common StockSEC:0001415889-25-000132:0
564 股@ US$2.581.0% 占其流量Common StockSEC:0001415889-24-021482:0
1,823 股@ US$5.49936.9% 占其流量Common StockSEC:0001415889-24-019429:0
1,373 股@ US$5.81885.5% 占其流量Common StockSEC:0001415889-24-019228:0
15,000 股0Common StockSEC:0001415889-24-004233:0
2,717 股@ US$13.60225.2% 占其流量Common StockSEC:0001209191-24-000985:0
1,631 股@ US$15.0416.5% 占其流量Common StockSEC:0001209191-24-000379:0
26,000 股0Common StockSEC:0001209191-23-043523:0
7,345 股@ US$6.5232.7% 占其流量Common StockSEC:0001209191-23-041790:0
466 股@ US$7.342.3% 占其流量Common StockSEC:0001209191-23-041189:0
482 股@ US$11.06993.7% 占其流量Common StockSEC:0001209191-23-000485:0
11,000 股0Common StockSEC:0001209191-22-045064:0
50,000 股0Common StockSEC:0001209191-22-005923:0
About Pinto Shelly
Pinto Shelly is VP, Finance et Directeur Comptable at ALX Oncology Holdings INC (XNAS). Across 22 filings, the sampled recent filings from 2022-02-01 to 2026-03-23 show only sales, for a total amount of EUR 140979.